COVID-19: A Trial Studying the SARS-CoV-2 mRNA Vaccine CVnCoV to Learn About the Immune Response, the Safety, and the Degree of Typical Vaccination Reactions When CVnCoV is Given at the Same Time as a Flu Vaccine Compared to When the Vaccines Are Separately Given in Adults 60 Years of Age and Older

NCT04848467 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped The study cannot be conducted.

Conditions

SARS-CoV-2 Infection
Coronavirus Disease 2019 (COVID-19)

Interventions

BIOLOGICAL: SARS-CoV-2 mRNA Vaccine (CVnCoV)
BIOLOGICAL: Quadrivalent influenza vaccine (QIV)
OTHER: Placebo

Sponsor

Bayer

Collaborators

[object Object]